Fundraising FoxTullis Health Investors — Full Portfolio
29 tracked investments · listed companies and verified rows first
Alphatec Holdings designs and manufactures surgical systems and imaging technology for spine procedures, including integrated implants, nerve-monitoring equipment, and 3D imaging platforms that assist in surgical planning and outcomes assessment.
HealthtechCarlsbad, US
Terry M. Rich(Executive Officer, Director)Craig Hunsaker(Executive Officer)inJohn Allen(Executive Officer)Jeffrey Black(Executive Officer)Patrick S. Miles(Executive Officer, Director)J. Todd Koning(Executive Vice President and Chief Financial Officer)in
Board seatJames L. L. Tullis· per SEC Form D · $168M raise · filed Dec 2020
electroCore develops non-invasive vagus nerve stimulation (nVNS) medical devices, marketed as gammaCore, to treat patients suffering from pain and chronic conditions.
BiotechDigital HealthHardwareHealthtechMedical DevicesBasking Ridge, US
JP Errico(Executive Officer)inBrian Posner(Executive Officer)inDaniel S. Goldberger(Executive Officer, Director)Peter Staats(Director)inFrank Amato(Executive Officer)in
BoardTrevor Moody(Director)
PartnerJohn Tullis· led
Board seatJames L.L. TullisJames Tullis· per SEC Form D
Co-investorsFoothill VenturesMerck Global Health Innovation Fund
Exagen develops diagnostic and monitoring tests for autoimmune diseases, including tools to distinguish connective tissue disease and assess lupus prognosis and progression.
BiotechDigital HealthHealthtechMedical DevicesVista, US
Thierry Dervieux(Executive Officer)inWendy Swedick(Executive Officer)Fortunato R. Rocca(Executive Officer, Director)John Aballi(President & CEO)inJeffrey Black(Chief Financial Officer and Corporate Secretary)in
Board seatJames L.L. Tullis· per SEC Form D
Co-investorsCottonwood Technology FundEPIC VENTURESH.I.G. CapitalH.I.G. HealthBridge PartnersSun Mountain Capital
Hyperion DeFi is a U.S.
BiotechCrypto & Web3FintechHealthtechLaguna Hills, US
Michael Rowe(Executive Officer, Director)Hyunsu Jung(Chief Executive Officer)inBARRY BUTLER(Executive Officer)David(Chief Financial Officer)TSONTCHO IANCHULEV(Executive Officer, Director)
Board seatCurt LaBelle· per SEC Form D · $6M raise · filed Apr 2020
Co-investorsEshelman Ventures, LLC
RevBio Sciences develops Gemini, an intravenously administered formulation of phosphorylated hexaacyl disaccharide (PHAD) designed to reduce inflammation-related damage by reprogramming the innate immune system to respond to stress such as trauma and infection in an attenuated way.
BiotechHealthtechSan Diego, US
James M. Rolke(Executive Officer, Director)inJess Roper(Director)inChester S. Zygmont, III(Executive Officer)in
BoardGeorge F. Tidmarsh(Director)Jennifer Carver(Director)
Board seatCurt LaBelle· per SEC Form D · $4.4M raise · filed Apr 2021
Novocuff is a medical device company developing the Novocuff Cervical Control System, an investigational device aimed at improving outcomes for pregnancies affected by preterm prelabor rupture of membranes (PPROM) or cervical shortening.
FemTechHealthtechMedical DevicesMountain View, US
Donald Lee(Executive Officer)inAmelia Degenkolb(Executive Officer, Director)in
BoardLilly DeSouza Burr(Director)Rebecca Shmukler(Director)inShacey Petrovic(Director)in
Board seatCurt LaBelle· per SEC Form D · $28M raise · filed Jul 2024
Co-investorsForeground CapitalLaerdal Million Lives FundGlobal Health Investment Fund
Ophirex is a biotech company developing varespladib, an investigational oral capsule intended to treat snakebite envenomation by inactivating a key venom toxin found in most snake species.
BiotechDeep TechHealthtechCorte Madera, US
Jerry Harrison(Co-founder; Director)Matthew R. Lewin(Founder and Board Member)inJeremy Gowler(Chief Executive Officer & Board Director)inSara Carter(Executive)Timothy Platts-Mills(Executive)Dotson(Finance leader (Controller/Finance))
.jpg)
Board seatCurt LaBelle· per SEC Form D · $35M raise · filed Mar 2022
Co-investorsGlobal Health Investment Fund
Vedanta Biosciences is a clinical-stage biotech developing Live Biotherapeutic Products (LBP) based on defined consortia of bacteria to treat serious gastrointestinal diseases, with an initial focus on preventing recurrent Clostridium difficile infection.
BiotechHealthtechCambridge, US
Bernat Olle(Executive Officer, Director)inDaniel Couto(Executive Officer)inMark Mullikin(Executive Officer)inJeffrey Silber(Executive Officer)inChristopher Viehbacher(Director)
BoardJohn LaMattina(Director)in
Board seatCurt LaBelle· per SEC Form D · $118.5M raise · filed Aug 2024
Co-investorsAMR Action FundK2 HealthVenturesSalica InvestmentsSeventure PartnersBNP ParibasBNP Paribas Asset Management Europe+1 more
ATEC Spine develops surgical devices and approaches for spine surgery, targeting decompression, stabilization, and alignment for surgeons treating spinal pathologies.
HealthtechMedical DevicesRoboticsCarlsbad, US
Patrick S. Miles(Chairman and Chief Executive Officer)inCraig Hunsaker(Executive Vice President, People & Culture)inTodd Koning(Chief Financial Officer)inScott Lish(Chief Operating Officer)inTyson Marshall(General Counsel & Corporate Secretary)inDave Sponsel(Executive Vice President, Sales)
HealthtechWesley Chapel, US
Travis Bond(Executive Officer, Director, Promoter)Lisa Bond(Executive Officer, Director, Promoter)
BoardRyan Cortner(Director)John Tullis(Director)inAshok Subramanian(Director)David Lefell(Director)
Co-investorsGreycroft PartnersMerck Global Health Innovation Fund
Channel Medsystems (Cerene) develops easy-to-use medical devices for women's health, aimed at women and their gynecologists.
FemTechHealthtechMedical Devices
San Francisco, US
Brian McNabbinEric Applegate(Executive Officer, Director)David Applegate(Executive Officer, Director)
BoardRoss Jaffe(Director)Susan Choe(Director)in
Co-investorsKatalyst VenturesKatalyst.Ventures
Newton is an innovation company that develops therapeutic optical lenses for treating eye-related conditions like headaches, motion sickness, and neck pain caused by eye misalignment.
Digital HealthHardwareHealthtechMedical Devices
Yuval B.(Founder)in
Co-investorsTwenty Two VenturesY Combinator
TriSalus develops a therapeutic platform combining its Pressure-Enabled Drug Delivery (PEDD) method with immune-activating therapies to overcome intratumoral pressure and immunosuppression that limit treatment of liver and pancreatic tumors.
BiotechHealthtechMedical DevicesWestminster, US
Sean Murphy(Executive Officer, Director)inJennifer E. Stevens(Executive Officer)inRichard B. Marshak(Executive Officer)inMary Szela(Executive Officer, Director)Jodi Devlin(Executive Officer)inRobert H. Weiss(Chief Administrative Officer and Secretary)
Co-investorsOrbiMed
Developer of an intraosseous medicine technology platform; acquired by Teleflex in 2013.
Co-investorsTargeted Technology FundsTelegraph Hill Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
CXL OPHTHALMICS, INC.FirstString ResearchInPress TechnologiesSafeOp SurgicalSupplyproAdams Respiratory Therapeutics, Inc.Atritech, Inc.Coherex Medical, Inc.Genoptix, Inc.Ikano Therapeutics, Inc.Impulse Monitoring, Inc.Sirion Therapeutics, Inc.Surefire MedicalSynageva BioPharma Corp.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.